ALZAMEND NEURO, INC. Prepaid Insurance
ALZAMEND NEURO, INC. (ALZN) had Prepaid Insurance of $174.78 thousand as of 2026-07-31, per its 10-Q filed 2026-09-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidInsurance · last filed 2026-09-10
- 2026-07-31: Prepaid Insurance $174.78K.
- 2026-04-30: Prepaid Insurance $41.97K.
- 2026-01-31: Prepaid Insurance $100.89K.
- 2025-10-31: Prepaid Insurance $159.81K.
| Period end | Prepaid Insurance |
|---|---|
| 2026-07-31 | $174.78K 10-Q · filed 2026-09-10 |
| 2026-04-30 | $41.97K 10-Q · filed 2026-09-10 |
| 2026-01-31 | $100.89K 10-Q · filed 2026-03-11 |
| 2025-10-31 | $159.81K 10-Q · filed 2025-12-09 |
| 2025-07-31 | $202.38K 10-Q · filed 2025-09-10 |
| 2025-04-30 | $42.58K 10-K · filed 2026-07-22 |
| 2025-01-31 | $102.96K 10-Q · filed 2025-03-10 |
| 2024-10-31 | $163.33K 10-Q · filed 2024-12-11 |
| 2024-07-31 | $209.62K 10-Q · filed 2024-09-11 |
| 2024-04-30 | $60.52K 10-K · filed 2025-07-22 |
| 2024-01-31 | $148.05K 10-Q · filed 2024-03-25 |
| 2023-10-31 | $235.58K 10-Q · filed 2023-12-15 |
| 2023-07-31 | $311.53K 10-Q · filed 2023-09-13 |
| 2023-04-30 | $92.15K 10-K · filed 2024-07-30 |
| 2023-01-31 | $222.74K 10-Q · filed 2023-03-15 |
| 2022-10-31 | $353.33K 10-Q · filed 2022-12-12 |
| 2022-07-31 | $451.88K 10-Q · filed 2022-09-13 |
| 2022-04-30 | $155.88K 10-K · filed 2023-07-27 |
| 2022-01-31 | $370.18K 10-Q · filed 2022-03-15 |
| 2021-10-31 | $584.48K 10-Q · filed 2021-12-13 |
| 2021-07-31 | $155.88K 10-Q · filed 2022-09-13 |
| 2021-06-14 | $855.00K 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |